Randomized Controlled Trials as Topic
"Randomized Controlled Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.
| Descriptor ID |
D016032
|
| MeSH Number(s) |
E05.318.760.250.500.365.500 N05.715.360.775.088.500.387.500 N06.850.520.450.250.250.365.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Randomized Controlled Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Randomized Controlled Trials as Topic".
This graph shows the total number of publications written about "Randomized Controlled Trials as Topic" by people in this website by year, and whether "Randomized Controlled Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 4 | 5 |
| 2003 | 1 | 8 | 9 |
| 2004 | 0 | 5 | 5 |
| 2005 | 1 | 8 | 9 |
| 2006 | 0 | 9 | 9 |
| 2007 | 1 | 9 | 10 |
| 2008 | 2 | 10 | 12 |
| 2009 | 6 | 11 | 17 |
| 2010 | 3 | 10 | 13 |
| 2011 | 1 | 21 | 22 |
| 2012 | 2 | 16 | 18 |
| 2013 | 4 | 17 | 21 |
| 2014 | 3 | 18 | 21 |
| 2015 | 3 | 11 | 14 |
| 2016 | 9 | 33 | 42 |
| 2017 | 124 | 654 | 778 |
| 2018 | 137 | 695 | 832 |
| 2019 | 44 | 257 | 301 |
| 2020 | 61 | 193 | 254 |
| 2021 | 24 | 145 | 169 |
| 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Randomized Controlled Trials as Topic" by people in Profiles.
-
Pivoting during a pandemic: lessons learned from transitioning a multisite randomized controlled trial to a remote protocol in response to COVID-19. Transl Behav Med. 2021 12 14; 11(12):2187-2193.
-
Janus Kinase inhibitors for the treatment of hospitalized patients with COVID-19. Curr Opin Crit Care. 2021 10 01; 27(5):493-496.
-
Efficacy of face masks against respiratory infectious diseases: a systematic review and network analysis of randomized-controlled trials. J Breath Res. 2021 09 13; 15(4).
-
Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Sep 03; 22(1):584.
-
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 09 02; 9:CD013825.
-
Editorial: Reporting Clinical Trials with Important Modifications Due to Extenuating Circumstances, Including the COVID-19 Pandemic: CONSERVE 2021. Med Sci Monit. 2021 Aug 30; 27:e934514.
-
Response to "Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy". Am J Trop Med Hyg. 2021 08 30; 106(1):370.
-
Randomized Controlled Trials on COVID-19 Should Be Accurate and Trustworthy. Am J Trop Med Hyg. 2021 08 30; 106(1):369.
-
Intradermal immunization-a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines? Clin Microbiol Infect. 2022 01; 28(1):6-8.
-
The EPIPHA-KNEE trial: Explaining Pain to target unhelpful pain beliefs to Increase PHysical Activity in KNEE osteoarthritis - a protocol for a multicentre, randomised controlled trial with clinical- and cost-effectiveness analysis. BMC Musculoskelet Disord. 2021 Aug 28; 22(1):738.